Dr. Amgad M. Rabie

Drug Discovery & Medicinal Chemistry, Egypt

Email: amgadpharmacist1@yahoo.com

Qualifications

2018 to 2022 Ph.D., Harvard University, USA

2008 to 2017 M.Sc., Mansoura University, Egypt

2000 to 2006 B.Sc., Mansoura University, Egypt

Publications (Selected)

1. AM Rabie, (2022) Potent inhibitory activities of the adenosine analogue cordycepin on SARS-CoV-2 replication‏, ACS omega 7 (3), 2960-2969.
2. AM Rabie, (2021) Two antioxidant 2, 5-disubstituted-1, 3, 4-oxadiazoles (CoViTris2020 and ChloViD2020): successful repurposing against COVID-19 as the first potent multitarget anti-SARS-CoV-2, New Journal of Chemistry 45 (2), 761-771.
3. AM Rabie‏, (2021) Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug‏, Chemical Papers 75 (9), 4669-4685.
4. AM Rabie, AS Tantawy, SMI Badr ‏(2016), Design, synthesis, and biological evaluation of novel 5-substituted-2-(3, 4, 5-trihydroxyphenyl)-1, 3, 4-oxadiazoles as potent antioxidants, Am. J. Org. Chem 6, 54-80‏.
5. AM Rabie, (2021) CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy‏, Molecular Diversity 25 (3), 1839-1854.
6. AM Rabie, (2021) Cyanorona-20: The first potent anti-SARS-CoV-2 agent‏, International immunopharmacology 98, 107831‏.
7. AM Rabie, (2021) Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles, Chemico-Biological Interactions 343, 109480.
8. AM Rabie, (2021) Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain, Journal of Molecular Structure 1246, 131106‏.
9. AM Rabie, (2021) Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19, Current Research in Pharmacology and Drug Discovery 2, 100055‏.
10. AM Rabie, AS Tantawy, SMI Badr, (2018) Design, synthesis, and biological evaluation of new 5-substituted-1, 3, 4-thiadiazole-2-thiols as potent antioxidants‏, Researcher 10, 21-43.